Pages
Products
Cre Adeno-associated virus(AAV Serotype 5)

Cre Adeno-associated virus(AAV Serotype 5)

Cat.No. :  AAV00020Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 5 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00020Z
Description Cre Adeno-associated virus(AAV Serotype 5) which express Cre recombinase under the control CMV promoter. This product used in the Cre-lox system as a genetic tool to generate site-specific recombination of DNA between loxP sites in cultured cells and animal experiments.
Serotype AAV Serotype 5
Target Gene cre
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Adeno-associated virus (AAV) is a member of the parvovirus family, and its genome is a single-stranded DNA consisting of 4682 nucleotides. AAV is a dependent virus that requires other viruses such as adenovirus or herpes simplex virus, or auxiliary factors to provide auxiliary functions in order to replicate. In the absence of auxiliary viruses, after AAV infects cells, its genome will be integrated into the cell chromosome and become latent, without producing progeny viruses. AAV includes 12 different AAV serotypes. The corresponding cell surface receptors during the infection process of different serotypes are not the same, so different tissues and organs in the animal body show different affinities and infection efficiencies. Among them, AAV5 shows a certain affinity for the lungs, eyes, and nervous system. Cre recombinase is an enzyme that promotes recombination between specific DNA sequences (called loxP sites). When AAV5 is designed to carry the Cre recombinase gene, it can be used to activate or deactivate genes at loxP sites in a targeted manner, making it a powerful tool for researchers studying gene function and regulation.

Genetic changes caused by thalamic hemorrhage may contribute to the development of thalamic pain. RNA N6-methyladenosine (m6A) modification is an additional layer of gene regulation. Whether fat mass and obesity-associated protein (FTO), an m6A demethylase, is involved in hemorrhage-induced thalamic pain is unknown. In this study, FTO was detected in neuronal nuclei of the thalamus. FTO protein levels, but not mRNA, increased over time in the ipsilateral thalamus 1-14 days after microinjection of type IV collagenase (Coll IV). Intraperitoneal injection of MA or AAV5-Cre microinjection into the thalamus of Ftofl/fl mice attenuated Coll IV microinjection-induced ipsilateral thalamic TLR4 upregulation and tissue damage as well as the generation and maintenance of contralateral nociceptive hypersensitivity. Thalamic microinjection of AAV5-Fto increased TLR4 expression and induced hypersensitivity to mechanical, heat, and cold stimuli. Mechanistically, Coll IV microinjection produced an increase in FTO binding to Tlr4 mRNA, an FTO-dependent loss of m6A sites in Tlr4 mRNA and a reduction in the binding of YTHDF2 to Tlr4 mRNA in the ipsilateral thalamus. These findings suggest that FTO is involved in hemorrhage-induced thalamic pain by stabilizing TLR4 upregulation in thalamic neurons.

The researchers knocked down thalamic FTO in male Ftofl/fl mice by microinjecting AAV5-Cre into the unilateral thalamic VPL and VPM 5 weeks before Coll IV or by microinjecting saline into the same area. AAV5-Gfp was used as a negative control. In the entire ipsilateral thalamus of male Ftofl/fl mice microinjected with AAV5-Cre at Coll IV, the increase in FTO protein levels caused by Coll IV microinjection was significantly blocked 7 days after microinjection of AAV5-Cre (Figure 1A). Unexpectedly, male Ftofl/fl mice microinjected with AAV5-Cre failed to change the basal level of FTO protein in the ipsilateral thalamus 7 days after microinjection of saline (Figure 1A). Consistent with the above behavioral observations, significant mechanical allodynia, heat hyperalgesia, and cold hyperalgesia were observed on days 1, 3, and 7 after Coll IV microinjection in AAV5-Gfp pre-microinjected male Ftofl/fl mice contralaterally (but not ipsilaterally) (Figure 1B-F). However, these hyperalgesias were significantly reduced in Coll IV male Ftofl/fl mice pre-microinjected with AAV5-Cre (Figure 1B-D). Similar behavioral responses were observed in female Ftofl/fl mice.

Effect of thalamic pre-microinjection of AAV5-Cre on Coll IV microinjection-induced FTO protein expression and thalamic pain genesis in male Ftofl/fl mice.Figure 1. Effect of thalamic pre-microinjection of AAV5-Cre on Coll IV microinjection-induced FTO protein expression and thalamic pain genesis in male Ftofl/fl mice. (Fu G, et al., 2021)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Perfect tool

The Cre recombinase activity was robust, providing precise genetic modifications. It’s the perfect tool for anyone looking to streamline their gene-editing processes!

Canada

03/24/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction